Headquartered in Pittsburgh, Helomics is a division of Predictive Oncology Inc. Our mission is to improve outcomes for current and future cancer patients using a knowledge and AI-driven approach. We leverage our proprietary tumor profiling platform, a vast historical knowledgebase of 150K+ de-identified patient drug response profiles together with proven AI to deliver more precisely targeted therapies for patients.
Let us tell you about Helomics.
Helomics has a key proprietary technology platform and data pipeline that provides next-generation, AI- and data-driven services to Pharma and Diagnostic companies to accelerate the development of new precision therapies.
For BioPharma, Helomics improves the efficiency and cost effectiveness of the discovery of new drugs. For Clinicians, Helomics helps oncologists to individualize current therapies for patients.